Sir, Reply to: 'Four quadrant sclerotomies for uveal effusion syndrome'
We read with great interest the recent correspondence by Wang et al 1 referring to our case series entitled 'Medical therapy for uveal effusion syndrome'. 2 Wang et al suggested in their case report that even in cases of UES with localised subretinal fluid, a surgical intervention with sclerotomies performed in all four quadrants may be necessary to successfully manage the patient.
With UES being so rare in occurrence, evidence for treatment comes from case reports or case series. Until our case series, recommended therapy for the treatment of UES has been surgery.
As reported in our paper, we managed to completely resolve the UES with medical therapy alone in two patients, whereas the third patient had to undergo surgery in the left eye. We decided to perform the surgery in a stepwise manner; with two inferior sclerotomies initially, leaving the option of further two sclerotomies for subsequent procedure, should the first one fail to resolve the effusion. After the surgical procedure, UES resolved completely, his VA increased from 20/50 to 20/20 and no recurrence was observed until the present day.
The differences between our case and the one reported by Wang et al should also take into account the different findings in the histology of the sclera. In our case, even though the sclera was thickened, the histology did not show any abnormalities in connective tissue and there was no excessive accumulation of mucin. According to a study by Uyama et al, 3 final results of the surgery depend on the subtypes of UES (nanophthalmic eye vs eye with normal axial length; abnormal sclera vs normal sclera on histology).
From the reported case of Wang et al, it is not obvious whether medical therapy was introduced before the Supplementary Information accompanies this paper on Eye website (http://www.nature.com/eye) surgery or not; however, we believe that initial medical therapy may be a good approach to UES patients proceeding to surgery in refractory cases using a stepwise surgical approach.
During initial surgery, two sclerotomies may be sufficient as was the case in our patient, but in other patients (different UES subtypes) four sclerotomies may be necessary, as suggested by Wang et al to achieve resolution of the disease.
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Sir, Primary surgical posterior capsulotomy during phacovitrectomy
We read with interest the recent articles by Jalil et al 1 and Rahman and Stephenson, 2 describing good visual outcomes from combined phacoemulsification and pars plana vitrectomy. Posterior capsular opacification (PCO) is a common occurrence after phacovitrectomy and we note that the PCO rate in both papers was significant (5.8 and 8.3%, respectively). A previous study has estimated PCO incidence to be as high as 21.5% after phacovitrectomy. 3 Primary surgical posterior capsulotomy at the time of phacovitrectomy prevents post-operative PCO and this has been our standard clinical practice for several years. In this technique, the capsulotomy is performed at the start of vitrectomy using the vitreous cutter, after the intraocular lens (IOL) is implanted into the capsular bag, and results in a circular, centred, 4-mm diameter capsular opening. 4 Primary posterior capsulotomy ensures removal of the anterior vitreous and improves visualisation for intraoperative peeling of epiretinal or internal limiting membranes, and also improves the fundal view during the post-operative period. Primary capsulotomy with posterior optic buttonholing has been recently described but we have not found this to be necessary. 5 In our series of more than 1500 patients, we have not encountered IOL dislocation into the vitreous or IOL de-centration. This technique can be routinely used when implanting monofocal, multifocal, or toric IOLs. Our audited results have shown no difference in refractive outcomes between phacovitrectomy (with primary posterior capsulotomy) and phacoemulsification surgery alone.
We do not implant silicone lenses, but would advocate caution when such IOLs are used in a situation where silicone oil may be required. Silicone oil adherence to silicone IOLs is a well-recognised phenomenon that is notoriously difficult to treat. 6 The only disadvantage of primary posterior capsulotomy is that during fluid-air exchange, condensation on the posterior IOL surface can obscure the view of the posterior pole. In this circumstance, application of hydroxypropylmethylcellulose to the posterior lens surface will rapidly restore the fundal view.
